Members of the temperature module: T. Dziedzic (Poland), P. Michel (Switzerland), V. Papavasileiou (Greece), J. Petersson (Sweden), D. Staykov (Germany).

Slides:



Advertisements
Similar presentations
Advanced Piloting Cruise Plot.
Advertisements

Feichter_DPG-SYKL03_Bild-01. Feichter_DPG-SYKL03_Bild-02.
Copyright © 2003 Pearson Education, Inc. Slide 1 Computer Systems Organization & Architecture Chapters 8-12 John D. Carpinelli.
Chapter 1 The Study of Body Function Image PowerPoint
Copyright © 2011, Elsevier Inc. All rights reserved. Chapter 6 Author: Julia Richards and R. Scott Hawley.
Author: Julia Richards and R. Scott Hawley
1 Copyright © 2013 Elsevier Inc. All rights reserved. Appendix 01.
Properties Use, share, or modify this drill on mathematic properties. There is too much material for a single class, so you’ll have to select for your.
UNITED NATIONS Shipment Details Report – January 2006.
1. 2 Why are Result & Impact Indicators Needed? To better understand the positive/negative results of EC aid. The main questions are: 1.What change is.
1 RA I Sub-Regional Training Seminar on CLIMAT&CLIMAT TEMP Reporting Casablanca, Morocco, 20 – 22 December 2005 Status of observing programmes in RA I.
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
FACTORING ax2 + bx + c Think “unfoil” Work down, Show all steps.
Year 6 mental test 5 second questions
Year 6 mental test 10 second questions
1 Discreteness and the Welfare Cost of Labour Supply Tax Distortions Keshab Bhattarai University of Hull and John Whalley Universities of Warwick and Western.
Evidence-based approach to imaging-based thrombolysis beyond the 4
REVIEW: Arthropod ID. 1. Name the subphylum. 2. Name the subphylum. 3. Name the order.
PP Test Review Sections 6-1 to 6-6
ABC Technology Project
EU market situation for eggs and poultry Management Committee 20 October 2011.
Bright Futures Guidelines Priorities and Screening Tables
1 Undirected Breadth First Search F A BCG DE H 2 F A BCG DE H Queue: A get Undiscovered Fringe Finished Active 0 distance from A visit(A)
2 |SharePoint Saturday New York City
VOORBLAD.
15. Oktober Oktober Oktober 2012.
1 Breadth First Search s s Undiscovered Discovered Finished Queue: s Top of queue 2 1 Shortest path from s.
Copyright © 2012, Elsevier Inc. All rights Reserved. 1 Chapter 7 Modeling Structure with Blocks.
BIOLOGY AUGUST 2013 OPENING ASSIGNMENTS. AUGUST 7, 2013  Question goes here!
Factor P 16 8(8-5ab) 4(d² + 4) 3rs(2r – s) 15cd(1 + 2cd) 8(4a² + 3b²)
Basel-ICU-Journal Challenge18/20/ Basel-ICU-Journal Challenge8/20/2014.
1..
CONTROL VISION Set-up. Step 1 Step 2 Step 3 Step 5 Step 4.
© 2012 National Heart Foundation of Australia. Slide 2.
LO: Count up to 100 objects by grouping them and counting in 5s 10s and 2s. Mrs Criddle: Westfield Middle School.
Understanding Generalist Practice, 5e, Kirst-Ashman/Hull
GG Consulting, LLC I-SUITE. Source: TEA SHARS Frequently asked questions 2.
Addition 1’s to 20.
Model and Relationships 6 M 1 M M M M M M M M M M M M M M M M
25 seconds left…...
H to shape fully developed personality to shape fully developed personality for successful application in life for successful.
Januar MDMDFSSMDMDFSSS
Week 1.
Analyzing Genes and Genomes
We will resume in: 25 Minutes.
©Brooks/Cole, 2001 Chapter 12 Derived Types-- Enumerated, Structure and Union.
Essential Cell Biology
Intracellular Compartments and Transport
PSSA Preparation.
Immunobiology: The Immune System in Health & Disease Sixth Edition
Essential Cell Biology
Immunobiology: The Immune System in Health & Disease Sixth Edition
1 Chapter 13 Nuclear Magnetic Resonance Spectroscopy.
Immunobiology: The Immune System in Health & Disease Sixth Edition
Energy Generation in Mitochondria and Chlorplasts
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 71 Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen.
Monitoring: What, when and how long? George Ntaios University of Thessaly, Larissa, Greece.
A short introduction on
Non Steroidal Anti Inflammatory Drugs, Nonopioid Analgesics By S.Bohlooli, PhD.
Stroke in the era of NOACs George Ntaios MD, MSc (Stroke Medicine), PhD University of Thessaly, Greece Oslo 11/12/2015.
Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen 1.
Presentation transcript:

Members of the temperature module: T. Dziedzic (Poland), P. Michel (Switzerland), V. Papavasileiou (Greece), J. Petersson (Sweden), D. Staykov (Germany). Chairs of the ESO guidelines committee: J. Mas (France), T. Steiner (Germany). Nice, ESC2014 ESO Guidelines: Temperature management in acute ischaemic stroke George Ntaios MD, MSc (ESO Stroke Medicine), PhD, FESO University of Thessaly, Larissa, Greece

Disclosures Scholarships: European Stroke Organization; Hellenic Society of Atherosclerosis. Honoraria: Medtronic; Quintiles; CHUV; Belgian Stroke Council. Speaker fees: Sanofi; Boehringer-Ingelheim. Consultant fees: Boehringer-Ingelheim. Support to attend conferences: Bayer; Sanofi-Aventis; Pfizer; Lundbeck; Boehringer-Ingelheim; Galenica; Elpen; Bristol Myers Squibb. Participation in trials: – ENOS / National coordinator. (Greece) – BPREVISE / Principal investigator. – FOURIER / Sub-investigator. – GLORIA / Sub-investigator.

P opulation Hyperthermic patients with acute ischemic stroke I ntervention Treatment of hyperthermia C omparator No treatment O utcome Functional outcome / Mortality PICO1

1. cerebrovascular disorders/ or basal ganglia cerebrovascular disease/ or brain ischemia/ or exp brain infarction/ or hypoxia-ischemia, brain/ or carotid artery diseases/ or carotid artery thrombosis/ or carotid artery, internal, dissection/ or intracranial arterial diseases/ or cerebral arterial diseases/ or infarction, anterior cerebral artery/ or infarction, middle cerebral artery/ or infarction, posterior cerebral artery/ or exp "intracranial embolism and thrombosis"/ or exp stroke/ or vertebral artery dissection/ 2. (isch?emi$ adj6 (stroke$ or apoplex$ or cerebral vasc$ or cerebrovasc$ or cva or attack$)).tw. 3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle cerebr$ or mca$ or anterior circulation or basilar artery or vertebral artery) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw or 2 or 3 5. Fever/ 6. body temperature/ 7. (fever$ or hyperthermi$ or pyrexi$).tw. 8. (temperature$ adj5 (high$ or rise or raised or elevated or change$ or fluctuat$)).tw or 6 or 7 or Hypothermia, induced/ 11. cryotherapy/ or body temperature regulation/ 12. cold temperature/ or ice/ or extreme cold/ 13. exp antipyretics/ or exp Anti-Inflammatory Agents, Non-Steroidal/ or exp steroids/ or exp adrenal cortex hormones/ 14. acetaminophen/ or aspirin/ or diflunisal/ or ibuprofen/ or dipyrone/ or diclofenac/ or ketoprofen/ or naproxen/ or flurbiprofen/ or indomethacin/ or tolmetin/ or sulindac/ or etodolac/ or ketorolac/ or piroxicam/ or mefenamic acid/ or meclofenamic acid/ or flufenamic acid/ or prednisolone/ or prednisone/ or cortisone/ or hydrocortisone/ or methylprednisolone/ or dexamethasone/ 15. (fever$ adj3 (control$ or manage$)).tw. 16. (hypothermi$ adj5 (therapeutic or artificial or induced or induction or intentional or therap$ or process or protocol$ or protective or cap or caps or helmet$ or scalp)).tw. 17. (temperature$ adj5 (lower$ or low or decreas$ or reduc$ or normal or control$ or management)).tw. 18. normothermi$.tw. 19. ((cool or cold) adj5 (therap$ or temperature$ or device$ or equipment or fluid or catheter$ or bath$)).tw. 20. (cryother$ or cryogen$ or cryotreat$).tw. 21. (cooling or cooled or chilling or chilled or cools or coolcap or coolant or ice or icepack$ or cold water or iced water or water blanket or sponging or bathing or fan or fanning or coolgard).tw. 22. ((cool or cold) adj5 (blanket$ or collar or helmet or hood)).tw. 23. (antipyretic$ or anti-pyretic$ or antifebril$ or anti-febril$ or antiinflammatory or anti-inflammatory or NSAID$ or steroid$ or corticosteroid$ or glucocorticoid$ or corticoid$ or adrenal cortex hormone$ or acetaminophen or paracetamol or aspirin or acetylsalicylic acid or acetyl salicylic acid or ibuprofen or metamizole or dipyrone or diclofenac or ketoprofen or diflunisal or salsalate or naproxen or fenoproxen or dexketoprofen or flurbiprofen or oxaprozin or loxoprofen or indomethacin or tolmetin or sulindac or etodolac or ketorolac or aceclofenac or piroxicam or meloxicam or tenoxicam or droxicam or lornoxicam or isoxicam or mefenamic acid or meclofenamic acid or flufenamic acid or tolfenamic acid or celecoxib or rofecoxib or valdecoxib or parecoxib or lumiracoxib or etoricoxib or firocoxib or nimesulide or licofelone or prednisolone or prednisone or cortisone or cortisol or hydrocortisone or methylprednisolone or dexamethasone).tw. 24. or/ and 9 and Fever/dt, th [Drug Therapy, Therapy] and or exp animals/ not humans.sh not heat stroke/ or heat stroke.tw not 31

PICO1 Potentially relevant papers identified and screened for retrieval n=3501 Studies excluded during initial screening n=3347 Studies retrieved for more detailed evaluation n=154 Studies excluded during detailed evaluation n=151 Studies included in the meta-analysis n=3

PICO1 – functional outcome

P opulation Hyperthermic patients with acute ischemic stroke I ntervention Treatment of hyperthermia C omparator No treatment O utcome Mortality PICO1 - mortality

PICO1 – Grade Evidence Profile

PICO1 – Recommendations Due to the very low quality of current evidence, no specific recommendation can be made about the usefulness of treatment of hyperthermia to improve functional outcome or decrease mortality in hyperthermic patients with acute ischaemic stroke.

P opulation Normothermic patients with acute ischemic stroke I ntervention Prevention of hyperthermia C omparator No treatment O utcome Functional outcome / Mortality PICO2

1. cerebrovascular disorders/ or basal ganglia cerebrovascular disease/ or brain ischemia/ or exp brain infarction/ or hypoxia-ischemia, brain/ or carotid artery diseases/ or carotid artery thrombosis/ or carotid artery, internal, dissection/ or intracranial arterial diseases/ or cerebral arterial diseases/ or infarction, anterior cerebral artery/ or infarction, middle cerebral artery/ or infarction, posterior cerebral artery/ or exp "intracranial embolism and thrombosis"/ or exp stroke/ or vertebral artery dissection/ 2. (isch?emi$ adj6 (stroke$ or apoplex$ or cerebral vasc$ or cerebrovasc$ or cva or attack$)).tw. 3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle cerebr$ or mca$ or anterior circulation or basilar artery or vertebral artery) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw or 2 or 3 5. fever/pc 6. (normothermia or normothermic or afebrile or without fever or no fever).tw. 7. ((fever$ or hyperthermi$ or pyrexi$) adj5 (prevent$ or prophylaxis or prophylactic or protect$)).tw. 8. (temperature$ adj5 (high$ or rise or raised or elevated or change$ or fluctuat$) adj5 (prevent$ or prophylaxis or prophylactic or protect$)).tw. 9. ((maintain or maintenance) adj5 (normothermi$ or (normal adj3 temperature))).tw. 10. fever/ and (prevent$ or prophylaxis or prophylactic or protect$).tw or 6 or 7 or 8 or 9 or Hypothermia, induced/ 13. cryotherapy/ or body temperature regulation/ 14. cold temperature/ or ice/ or extreme cold/ 15. exp antipyretics/ or exp Anti-Inflammatory Agents, Non-Steroidal/ or exp steroids/ or exp adrenal cortex hormones/ 16. acetaminophen/ or aspirin/ or diflunisal/ or ibuprofen/ or dipyrone/ or diclofenac/ or ketoprofen/ or naproxen/ or flurbiprofen/ or indomethacin/ or tolmetin/ or sulindac/ or etodolac/ or ketorolac/ or piroxicam/ or mefenamic acid/ or meclofenamic acid/ or flufenamic acid/ or prednisolone/ or prednisone/ or cortisone/ or hydrocortisone/ or methylprednisolone/ or dexamethasone/ 17. (hypothermi$ adj5 (therapeutic or artificial or induced or induction or intentional or therap$ or process or protocol$ or protective or cap or caps or helmet$ or scalp)).tw. 18. (temperature$ adj5 (lower$ or low or decreas$ or reduc$ or control$ or manage$ or monitor$)).tw. 19. ((cool or cold) adj5 (therap$ or temperature$ or device$ or equipment or fluid or catheter$ or bath$)).tw. 20. (cryother$ or cryogen$ or cryotreat$).tw. 21. (cooling or cooled or chilling or chilled or cools or coolcap or coolant or ice or icepack$ or cold water or iced water or water blanket or sponging or bathing or fan or fanning or coolgard).tw. 22. ((cool or cold) adj5 (blanket$ or collar or helmet or hood)).tw. 23. (antipyretic$ or anti-pyretic$ or antifebril$ or anti-febril$ or antiinflammatory or anti-inflammatory or NSAID$ or steroid$ or corticosteroid$ or glucocorticoid$ or corticoid$ or adrenal cortex hormone$ or acetaminophen or paracetamol or aspirin or acetylsalicylic acid or acetyl salicylic acid or ibuprofen or metamizole or dipyrone or diclofenac or ketoprofen or diflunisal or salsalate or naproxen or fenoproxen or dexketoprofen or flurbiprofen or oxaprozin or loxoprofen or indomethacin or tolmetin or sulindac or etodolac or ketorolac or aceclofenac or piroxicam or meloxicam or tenoxicam or droxicam or lornoxicam or isoxicam or mefenamic acid or meclofenamic acid or flufenamic acid or tolfenamic acid or celecoxib or rofecoxib or valdecoxib or parecoxib or lumiracoxib or etoricoxib or firocoxib or nimesulide or licofelone or prednisolone or prednisone or cortisone or cortisol or hydrocortisone or methylprednisolone or dexamethasone).tw. 24. or/ and 11 and *Fever/pc and or exp animals/ not humans.sh not heat stroke/ or heat stroke.tw not (neonat$ or newborn$ or new born or pediatric or paediatric or birth or infant or infants or perinatal or peri-natal or baby or babies or child or children).ti not 32

PICO2 Potentially relevant papers identified and screened for retrieval n=833 Studies excluded during initial screening n=820 Studies retrieved for more detailed evaluation n=13 Studies excluded during detailed evaluation n=9 Studies included in the meta-analysis n=4

PICO2 – functional outcome

P opulation Normothermic patients with acute ischemic stroke I ntervention Prevention of hyperthermia C omparator No treatment O utcome Mortality PICO2

PICO2 - mortality

PICO2 - Grade Evidence Profile

PICO2 – Recommendations We recommend against the prevention of hyperthermia as a means to improve functional outcome in normothermic patients with acute ischaemic stroke. Due to the very low quality of current evidence, no specific recommendation can be made for the usefulness of the prevention of hyperthermia to reduce mortality in normothermic patients with acute ischaemic stroke.

P opulation Patients with acute ischemic stroke I ntervention Induction of hypothermia C omparator No intervention O utcome Functional outcome / Mortality PICO3

1. cerebrovascular disorders/ or basal ganglia cerebrovascular disease/ or brain ischemia/ or exp brain infarction/ or hypoxia-ischemia, brain/ or carotid artery diseases/ or carotid artery thrombosis/ or carotid artery, internal, dissection/ or intracranial arterial diseases/ or cerebral arterial diseases/ or infarction, anterior cerebral artery/ or infarction, middle cerebral artery/ or infarction, posterior cerebral artery/ or exp "intracranial embolism and thrombosis"/ or exp stroke/ or vertebral artery dissection/ 2. (isch?emi$ adj6 (stroke$ or apoplex$ or cerebral vasc$ or cerebrovasc$ or cva or attack$)).tw. 3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle cerebr$ or mca$ or anterior circulation or basilar artery or vertebral artery) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw or 2 or 3 5. Hypothermia, induced/ 6. cryotherapy/ 7. cold temperature/ or ice/ or extreme cold/ or shivering/ 8. (hypothermi$ adj5 (therapeutic or artificial or induce or induced or induction or intentional or therap$ or process or protocol$ or protective or neuroprotect$ or cap or caps or helmet$ or scalp)).tw. 9. hypothermia/ and (therapeutic or artificial or induce or induced or induction or intentional or therap$ or process or protocol$ or protective or neuroprotect$ or cap or caps or helmet$ or scalp).tw. 10. (temperature$ adj5 (lower$ or decreas$ or reduc$ or drop$)).tw. 11. body temperature/ or temperature/ or skin temperature/ 12. (lower$ or decreas$ or reduc$ or drop$).tw and ((cool or cold or ice-cold) adj5 (therap$ or temperature$ or device$ or equipment or fluid or catheter$ or bath$ or air)).tw. 15. (cryother$ or cryogen$ or cryotreat$ or shiver$).tw. 16. (cooling or cooled or chilling or chilled or cools or coolcap or coolant or ice or icepack$ or cold water or iced water or water blanket or sponging or bathing or fan or fanning or coolgard).tw. 17. ((cool or cold or ice-cold) adj5 (blanket$ or collar or helmet or hood)).tw or 6 or 7 or 8 or 9 or 10 or 13 or 14 or 15 or 16 or and exp animals/ not humans.sh not heat stroke/ or heat stroke.tw not (neonat$ or newborn$ or new born or pediatric or paediatric or birth or infant or infants or perinatal or peri-natal or baby or babies or child or children).ti not 24

PICO3 Potentially relevant papers identified and screened for retrieval n=4790 Studies excluded during initial screening n=4729 Studies retrieved for more detailed evaluation n=61 Studies excluded during detailed evaluation n=55 Studies included in the meta-analysis n=6

PICO3 – functional outcome

P opulation Patients with acute ischemic stroke I ntervention Induction of hypothermia C omparator No intervention O utcome Mortality PICO3

PICO3 - mortality

PICO3 - Grade Evidence Profile

PICO3 – Recommendations Due to the low quality of current evidence, no specific recommendation can be made about the usefulness of induced hypothermia in patients with acute ischaemic stroke.

PICO 1-3 – Recommendations For all the above questions where evidence is insufficient, we encourage the recruitment of patients in randomized controlled trials.